Literature DB >> 19414408

Intraportal injection of porcine multipotent mesenchymal stromal cells augments liver regeneration after portal vein embolization.

Vaclav Liska1, Przemyslav Slowik, Elke Eggenhofer, Vladislav Treska, Phillip Renner, Felix C Popp, Hynek Mirka, Jiri Kobr, Roman Sykora, Hans-Juergen Schlitt, Lubos Holubec, Alena Chlumska, Tomas Skalicky, Martin Matejovic, Marc H Dahlke.   

Abstract

UNLABELLED: Portal vein embolization (PVE) can be used prior to liver surgery to increase the volume of the remaining liver tissue after an extensive resection. However, the application of PVE is limited and new strategies to augment liver regeneration by cellular therapy are promising alternatives.
MATERIALS AND METHODS: The influence of syngeneic multipotent mesenchymal stromal cells (MSC) on liver regeneration was analysed after the ligation of the right portal vein branches in a porcine model, closely mimicking the situation of human surgery. Liver regeneration was monitored by ultrasonography, immunohistological analysis and serum biochemistry.
RESULTS: The volume of the contra-lateral, non-ligated liver lobe increased in all piglets after portal vein ligation. This hyperplasia occurred earlier and was more pronounced in those piglets receiving MSC infusions as compared to non-treated controls. Biochemical liver function was stable in all pigs. Only solitary transplanted MSC were detected in recipient livers two weeks after the infusion.
CONCLUSION: The infusion of porcine MSC into the portal vein in a setting of liver regeneration after surgical resection leads to accelerated and augmented hyperplasia. This effect is most likely due to bystander effects of the transplanted MSC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414408

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Chronological changes in the liver after temporary partial portal venous occlusion.

Authors:  Koji Hamasaki; Susumu Eguchi; Akihiko Soyama; Masaaki Hidaka; Mitsuhisa Takatsuki; Fumihiko Fujita; Kengo Kanetaka; Shigeki Minami; Tamotsu Kuroki
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

2.  Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation.

Authors:  Yang Tian; Jingcheng Wang; Wei Wang; Yuan Ding; Zhongquan Sun; Qiyi Zhang; Yan Wang; Haiyang Xie; Sheng Yan; Shusen Zheng
Journal:  Stem Cell Res Ther       Date:  2016-10-27       Impact factor: 6.832

3.  Prednisolone and mesenchymal stem cell preloading protect liver cell migration and mitigate extracellular matrix modification in transplanted decellularized rat liver.

Authors:  Atefeh Yaghoubi; Negar Azarpira; Saied Karbalay-Doust; Sajad Daneshi; Zahra Vojdani; Tahereh Talaei-Khozani
Journal:  Stem Cell Res Ther       Date:  2022-01-28       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.